Medgene Labs is an animal health company focused on developing diagnostic and therapeutic products for economically significant vector-borne or infectious diseases that are zoonotic or transmitted between species, including humans.
Medgene Labs provides monoclonal antibodies and services to its strategic partners. Medgene Labs' initial target market is the animal health industry, given the significant market need and prospective partnerships. Additionally, Medgene Labs' proprietary in vitro system has generated interest with global pharmaceutical companies for its ability to produce human monoclonal antibodies.
Click here to listen to Sue Lancaster discuss the exciting grant that Medgene Labs has received.